Insider Transactions in Q1 2025 at Baxter International Inc (BAX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2025
|
Jeanne K Mason EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,696
+7.29%
|
-
|
|
Mar 06
2025
|
Jeanne K Mason EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,375
-2.32%
|
$153,125
$35.44 P/Share
|
|
Mar 06
2025
|
Reaz Rasul EVP,Group Pres,Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
26,220
+17.38%
|
-
|
|
Mar 06
2025
|
Reaz Rasul EVP,Group Pres,Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
9,341
-8.67%
|
$326,935
$35.44 P/Share
|
|
Mar 06
2025
|
David S. Rosenbloom EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
17,658
+12.6%
|
-
|
|
Mar 06
2025
|
David S. Rosenbloom EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,922
-4.49%
|
$172,270
$35.44 P/Share
|
|
Mar 06
2025
|
Alok Sonig EVP,Group President,Pharma |
BUY
Grant, award, or other acquisition
|
Direct |
29,966
+18.7%
|
-
|
|
Mar 06
2025
|
Alok Sonig EVP,Group President,Pharma |
SELL
Payment of exercise price or tax liability
|
Direct |
10,839
-9.75%
|
$379,365
$35.44 P/Share
|
|
Mar 06
2025
|
Anita A Zielinski SVP, CAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
17,123
+50.0%
|
-
|
|
Mar 06
2025
|
James W Borzi EVP,Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,989
+12.02%
|
-
|
|
Mar 06
2025
|
James W Borzi EVP,Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,262
-4.91%
|
$114,170
$35.44 P/Share
|
|
Mar 06
2025
|
Joel T. Grade EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
29,538
+19.96%
|
-
|
|
Mar 06
2025
|
Joel T. Grade EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,306
-4.62%
|
$150,710
$35.44 P/Share
|
|
Mar 06
2025
|
Heather Knight EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,674
+16.75%
|
-
|
|
Mar 06
2025
|
Heather Knight EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,634
-8.78%
|
$477,190
$35.44 P/Share
|
|
Mar 03
2025
|
David S. Rosenbloom EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,312
-1.18%
|
$44,608
$34.86 P/Share
|
|
Mar 03
2025
|
Alok Sonig EVP,Group President,Pharma |
SELL
Payment of exercise price or tax liability
|
Direct |
1,936
-1.71%
|
$65,824
$34.86 P/Share
|
|
Mar 03
2025
|
James W Borzi EVP,Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,339
-1.98%
|
$45,526
$34.86 P/Share
|
|
Mar 03
2025
|
Heather Knight EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,344
-2.11%
|
$113,696
$34.86 P/Share
|
|
Mar 03
2025
|
Jeanne K Mason EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,479
-0.78%
|
$50,286
$34.86 P/Share
|
|
Mar 03
2025
|
Reaz Rasul EVP,Group Pres,Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
1,987
-1.81%
|
$67,558
$34.86 P/Share
|
|
Feb 05
2025
|
David Brent Shafer Interim CEO and Chair |
BUY
Grant, award, or other acquisition
|
Direct |
76,289
+45.92%
|
-
|
|
Jan 31
2025
|
Christopher A. Toth EVP, Group Pres, Kidney Care |
SELL
Payment of exercise price or tax liability
|
Direct |
25,372
-19.43%
|
$811,904
$32.56 P/Share
|